West Pharmaceutical Services Inc (WST)
335.56
+7.17
(+2.18%)
USD |
NYSE |
Jan 03, 16:00
335.62
+0.06
(+0.02%)
Pre-Market: 20:00
West Pharmaceutical Services Research and Development Expense (Annual): 68.40M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Merit Medical Systems Inc | 82.73M |
| Repligen Corp | 42.72M |
| Perspective Therapeutics Inc | 21.31M |
| Xtant Medical Holdings Inc | 1.336M |
| Catheter Precision Inc | 0.475M |